person

Gunnar T.

Country
Norway
Department
Clinical Cancer Research Unit

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
14
Sites with multiple studies

Has run more than one trial at 14 of 120 partner sites.

Specializations

Urologic Oncology

The investigator specializes in treating advanced forms of bladder cancer, with particular emphasis on muscle-invasive bladder cancer and metastatic urothelial cancer.

  • Muscle-Invasive Bladder Cancer Management
  • Advanced Urothelial Carcinoma Treatment
  • Locally Advanced Disease Therapies

Their research encompasses both neoadjuvant treatment approaches and novel therapeutic combinations for bladder malignancies.

Immunotherapy Applications

The investigator focuses on implementing immunotherapeutic approaches in urologic cancers, particularly exploring the integration of checkpoint inhibitors in treatment protocols.

  • Combination Immunotherapy Strategies
  • Novel Immunotherapy Agents
  • Maintenance Therapy Protocols

Their work includes evaluating immune-based interventions in both pre-surgical and advanced disease settings.

Treatment Innovation

The investigator develops multimodal treatment approaches, combining traditional chemotherapy with emerging therapeutic agents for urologic cancers.

  • Targeted Therapy Development
  • Combination Treatment Strategies
  • Progressive Disease Management

Their research encompasses both standard-of-care treatments and innovative therapeutic combinations.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.